HomeSHTDF • OTCMKTS
add
Sinopharm Group Co Ltd
Nakaraang pagsara
$2.30
Sakop ng taon
$1.97 - $2.95
Market cap
63.52B HKD
Average na Volume
20.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 147.36B | -5.19% |
Gastos sa pagpapatakbo | 6.78B | 4.18% |
Net na kita | 1.85B | -26.34% |
Net profit margin | 1.26 | -22.22% |
Kita sa bawat share | — | — |
EBITDA | 4.76B | -25.05% |
Aktuwal na % ng binabayarang buwis | 22.34% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 43.33B | 26.05% |
Kabuuang asset | 429.58B | 2.85% |
Kabuuang sagutin | 307.15B | 0.84% |
Kabuuang equity | 122.43B | — |
Natitirang share | 3.12B | — |
Presyo para makapag-book | 0.10 | — |
Return on assets | 2.44% | — |
Return on capital | 4.69% | — |
Cash Flow
Net change in cash
| (CNY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.85B | -26.34% |
Cash mula sa mga operasyon | -20.50B | -678.47% |
Cash mula sa pag-invest | -519.26M | -167.92% |
Cash mula sa financing | 10.78B | 5,713.58% |
Net change in cash | -10.24B | -512.13% |
Malayang cash flow | 2.71B | 108.45% |
Tungkol
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Itinatag
2003
Website
Mga Empleyado
113,635
